Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06592599
Title Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Stanford University
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University RECRUITING Palo Alto California 94304 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field